Latest News｜Institute for Biotechnology and Medicine Industry│IBMI

Latest News

Date	Subject	Media
2026-01-15	PharmaEngine’s First-Line Pancreatic Cancer Therapy and GNTbm’s New Breast Cancer Drug Approved for NHI Reimbursement, Effective Next Month	Investor
2026-01-15	Elixiron Immunotherapeutics Targets Emerging Stock Market Listing by Year-End, to Launch Phase II Vitiligo Trial in the Second Half	Investor
2026-01-15	Startup Update \| Chronic Disease AI Smart Healthcare Platform Health2Sync to List on the Emerging Stock Market Today	National Innovation Award
2026-01-15	Jensen Huang Has Also Invested in It: AI Drug Discovery Startup Iambic Shares Proprietary Technology at the Asia Medical Technology Innovation Forum	Commercial Times
2026-01-15	LAGIS to List on the TPEx in Mid-December, Multiple Growth Engines Target Double-Digit Growth Next Year	Investor
2026-01-15	GNTbm’s Breast Cancer Drug Kepida Granted National Health Insurance Reimbursement, Effective December 1	Money-link
2026-01-15	Genomics Wins Nine LDT Approvals in One Go, Targeting the US$100 Billion Genetic Testing Market	Economic Daily News
2026-01-15	MedTex 2025 to Debut on December 3, Bringing Six Global Capital Giants and Ten Leading International Biotech Startups to Taiwan	Economic Daily News
2026-01-14	Foresee Pharmaceuticals Grants Global Exclusive License of MMP-12 to Related Party QPS, with Total Deal Value and Milestones Up to US$584 Million	Investor
2026-01-14	Biotech Stocks Post First-Three-Quarter Earnings; Top 10 Rankings See Major Shake-Up, with This Stock Retaining EPS Crown at NT$21.34	Commercial Times

■ Most Watched

■ Industry Watch

■ IBMI News

Information appearing on this website (images and texts, unless otherwise indicated) is the property of IBMI. To use or share, please indicate the source.

Address：9F., No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City , Taiwan (R.O.C.) Contact Number：(02)2655-8168 Fax：(02)2655-7978